Article Details

AstraZeneca, Hutchmed begin phase 3 trial of Orpathys, Tagrisso combo in lung cancer patients

Retrieved on: 2021-11-28 11:00:35

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca, Hutchmed begin phase 3 trial of Orpathys, Tagrisso combo in lung cancer patients. View article details on hiswai:

Excerpt

Hong Kong: HUTCHMED (China) Limited and AstraZeneca PLC have initiated SACHI, a China Phase III study of ORPATHYS (savolitinib), an oral, potent, ...

Article found on: medicaldialogues.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up